XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | nl | no | nz | pt | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US

18,400 resources

By Version

R2: 0
R2B: 0
R3: 524
R4: 17,438
R4B: 0
R5: 438
R6: 0

By Authority

none: 1,998
hl7: 16,400
national: 2

Start Prev Rows 6200 - 6400 Next

Package	Version	Identity	Name/Title	Status	Date	Auth
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.615	Physical Disability	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.616	Financial difficulty	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.617	Vitreous exam findings	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.619	Scleral depressed exam	active	2020-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.629	Post operative follow up	active	2020-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.67	Breastfeeding	active	2017-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.69	Stable and Unstable Angina	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.70	Ischemic Heart Disease or Related Diagnoses	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.71	Cerebrovascular Disease Stroke or TIA	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.73	Breastfeeding	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.85	Familial Hypercholesterolemia	active	2023-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.89	Rhabdomyolysis	active	2017-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.9	Outpatient Encounters for Preventive Care	active	2019-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.91	Familial Hypercholesterolemia	active	2021-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.93	Hypercholesterolemia ICD 9	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.97	High Intensity Statin Therapy	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1047.98	Moderate Intensity Statin Therapy	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1056.50	HIV Lab Tests	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1056.51	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1056.52	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1056.53	Indicators of Human Immunodeficiency Virus (HIV)	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1056.71	Human Immunodeficiency Virus (HIV) Viral Load	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.10	ARBs (Angiotensin Receptor Blockers)	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1000	OIA_V2_GLP1s_RxNorms	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1001	OIA_V2_PCSK9s_RxNorms	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1002	OIA_RFs_Secondary_Prevention_ICD10	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1003	OIA_RFs_Secondary_Prevention_SNOMED	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1004	OIA_RFs_Secondary_Prevention_CPT	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1005	OIA_RFs_Secondary_Prevention_ICD_SM_CPT	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1006	OIA_Asthma_COPD_Combo_Meds	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1007	OIA_Asthma_COPD_Combo_Meds_SABA_SAMA	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1008	OIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICS	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1009	PAE_Patient_Conditions	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1012	PAE Conditions Short	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1016	OIA_TEST_VS	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1017	Triptan Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1018	NSAID Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1019	Statin Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1021	Penicillin Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1022	Macrolide Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1023	Quinolone Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1025	Beta blocker Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1026	ACE inhibitor Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1027	ARB Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1028	Sulfonylurea Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1030	DPP4i Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1031	GLP1RA Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1032	Beta blocker allergy intolerance	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1033	SGLT2i Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1034	MRA Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1036	Meglitinide Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1037	Alpha glucosidase inhibitor Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1038	TZD Allergy NDFRT	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1041	Hemoglobin	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1042	Hematocrit	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1043	Anemia for Erythropoesis Simulating Agents I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1044	Anemia for Erythropoesis Simulating Agents SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1045	Anemia for Erythropoesis Simulating Agents	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1046	AZT Meds	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1047	Ferritin	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1048	Knee pain I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1049	Knee pain SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.105	conditions_heartfailure	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1050	Knee pain	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1051	Knee decreased ROM SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1052	Knee effusion I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1054	Knee effusion	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1055	Knee crepitus SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1056	OIA_Antiemetics	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1057	OIA_PDE5is	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1058	OIA_Vitamins	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1059	OIA_Plavix	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1061	OIA_Oral_Contraceptives	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1063	OIA_Topical_Steroids	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1064	OIA_Cough_Cold_Meds	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1065	Antiperspirant aluminum salts	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1066	Antiperspirant anticholinergics	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1067	Antieplieptic medications	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1068	Antidepressant medications	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1069	Urinary incontinence SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1070	Urinary incontinence I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1071	Urinary incontinence	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1073	Hemifacial spasm SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1074	Hemifacial spasm I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1075	Hemifacial spasm	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1076	Spasmodic dysphonia SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1077	Physical therapy procedure SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1078	Occupational therapy SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1079	Hyperhidrosis SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1080	Hyperhidrosis I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1081	Hyperhidrosis	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1082	Tic disorder I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1083	Tic disorder SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1084	Tic disorder	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1085	Esophageal achalasia SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1086	Esophageal achalasia I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1087	Esophageal achalasia	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1088	ET propanolol or primidone	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1089	ET topiramate alprazolam or gabapentin	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.109	CKD stage4above I10	active	2024-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1090	Blephraospasm SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1091	Blepharospasm I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1092	Blepharospasm	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1093	Strabismus SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1094	Strabismus I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1095	Strabismus	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1096	Overactive bladder SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1097	Overactive bladder I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1098	Overactive bladder	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1099	Movement disorders SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.110	CKD stage4above SCT	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1100	Movement disorders I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1101	Movement disorders	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1102	Lateral epicondylitis SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1103	Lateral epicondyltisis I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1104	Lateral epicondylitis	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1105	Plantar fasciitis SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1106	Plantar fasciitis I10	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1107	Plantar fasciitits	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1108	Cardiac CT SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1109	Cardiac CT CPT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.111	CKD stage4above	active	2024-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1111	Cardiac CT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1112	Cardiac MRI SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1113	Cardiac MRI CPT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1114	Cardiac MRI	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1115	CT Angiography of Coronary Artery SCT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1116	CT Angiography of Coronary Artery CPT	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.1117	CT Angiography of Coronary Artery	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.120	Diabetic ketoacidosis SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.121	Diabetic ketoacidosis	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.146	Long Acting Muscarinic Antagonists (LAMA)	active	2023-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.159	conditions_COPD I10	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.175	Asthma	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.184	DigTx Virtual Reality Contraindications Visual Impairment	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.186	Beta blockers GDMT for heart failure	active	2023-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.188	medications_heart failure	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.197	Blood (Serum and Plasma) Potassium	active	2023-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.214	Type 1 Diabetes Mellitus SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.238	MRA mineralocorticoid receptor antagonists	active	2024-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.244	MRA Mineralocorticoid Receptor Antagonist Allergy	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.260	UACR SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.263	Pregnancy I10	active	2023-11	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.281	Statins Allergy SCT	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.282	Statin Allergy Intolerance	active	2025-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.314	relatedconditions_hyperlipidemia I10	active	2023-10	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.337	Migraine I10	active	2023-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.34	Blood pressure panel	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.35	Systolic Blood Pressure	active	2024-04	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.367	Trandolapril	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.369	Candesartan	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.377	Valsartan	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.397	eGFR	active	2025-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.412	Statin Moderate Intensity	active	2024-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.415	LDL Cholesterol	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.43	Urinalysis	active	2024-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.434	Insulin	active	2025-02	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.437	TZD Thiazolidinediones	active	2025-05	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.438	medications_T2DM	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.440	relatedconditions_T2DM SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.442	Blood Glucose	active	2024-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.459	Liver cancer	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.47	ACE inhibitor allergy SCT	active	2022-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.474	Allergy to Tdap Vaccine	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.475	Allergy to Td Vaccine	active	2023-06	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.481	medications_hypertension	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.492	Inhaled Corticosteroids Allergy	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.498	Metformin AllergyIntolerance SCT	active	2023-09	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.508	Abdominal aortic imaging CPT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.517	Hemoglobin A1c	active	2024-03	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.518	Drug hypersensitivity I10	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.519	Drug hypersensitivity SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.520	Drug hypersensitivity	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.521	Diabetic Kidney Disease I10	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.523	Diabetic kidney disease	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.524	Chronic Hepatitis SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.525	Chronic Hepatitis	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.527	OCS_Prednisone	active	2024-12	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.531	Anti IgE Medications	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.532	IL5 Antagonists	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.533	Mast cell stabilizers for asthma	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.534	Vasospastic disease I10	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.535	Vasospastic disease SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.536	Vasospastic disease	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.537	Hemiplegic and basilar migraine I10	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.538	Hemiplegic and basilar migraine SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.539	Hemiplegic and basilar migraine	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.540	Peptic ulcer disease I10	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.541	Peptic ulcer disease SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.542	Peptic ulcer disease	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.544	Bleeding disorder I10	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.545	Bleeding disorder SCT	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.548	Electronic cigarettes or Vaping	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.549	Bleeding disorder	active	2023-07	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.552	Triptans	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.553	CGRP receptor antagonists	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.554	Ditans	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.555	Ergots	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.556	Migraine specific NSAIDs	active	2023-08	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1078.557	OTC migraine analgesics	active	2023-08	hl7